Unlock the Potential of Intra-Cellular Therapies at Upcoming Investing Opportunities in May 2023!

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical leader in the research and commercialization of therapeutics for central nervous system (CNS) disorders, is excited to announce that they will be showcasing their innovative treatments at two upcoming investor conferences. Don’t miss your chance to learn more about how ITCI is making a difference in the lives of those suffering from CNS disorders.

Bank Of America Securities 2023 Health Care Conference

Tuesday, May 9th, 2023 marks a special day as it brings us to the future at 2:20 p.m. PT (5:20 p.m. ET). Imagine what lies ahead, and the possibilities that await!

2023 RBC Capital Markets Global Healthcare Conference

Wednesday, May 17th, 2023 marks the start of a new day, with the clock ticking to 10:30 a.m. ET! Get ready for a morning of possibilities and exciting opportunities!

Don’t miss out on our upcoming presentations! Log in to the Investor Relations section of our website 5-10 minutes before the event to register and gain access to our live and archived webcast. Download and install any necessary software and get ready to be informed and entertained.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a revolutionary biopharmaceutical company that is paving the way to a brighter future for those living with complex psychiatric and neurologic diseases. Utilizing Nobel Prize-winning research, the company has developed a unique and sophisticated intracellular approach to unlock the secrets of how therapies impact the functioning of cells within the body. With this groundbreaking approach, Intra-Cellular Therapies is paving the way to revolutionize the treatment of these diseases and provide better outcomes for patients.

Leave a Comment